Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
$15.32
-1.9%
$14.68
$9.57
$30.41
$2.12B0.961.53 million shs2.78 million shs
Encompass Health Corporation stock logo
EHC
Encompass Health
$119.07
-0.6%
$115.81
$82.74
$123.13
$12.00B0.89703,348 shs1.30 million shs
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
$13.22
-1.0%
$13.66
$6.62
$17.67
$1.14B1.27741,841 shs1.01 million shs
Select Medical Holdings Corporation stock logo
SEM
Select Medical
$14.83
-0.6%
$15.52
$14.03
$40.98
$1.91B1.34966,870 shs1.97 million shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
0.00%-2.67%+1.26%-1.16%-39.92%
Encompass Health Corporation stock logo
EHC
Encompass Health
0.00%-1.44%+0.28%+19.08%+40.32%
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
0.00%-5.74%-2.33%-8.94%+65.19%
Select Medical Holdings Corporation stock logo
SEM
Select Medical
0.00%-1.50%+3.09%-12.15%-56.38%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
3.5689 of 5 stars
3.41.00.03.42.72.50.0
Encompass Health Corporation stock logo
EHC
Encompass Health
4.7642 of 5 stars
2.65.01.75.02.42.51.9
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
2.5375 of 5 stars
3.23.00.00.01.71.71.3
Select Medical Holdings Corporation stock logo
SEM
Select Medical
4.9985 of 5 stars
3.43.02.54.82.54.25.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
2.75
Moderate Buy$43.71185.34% Upside
Encompass Health Corporation stock logo
EHC
Encompass Health
3.22
Buy$127.006.66% Upside
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
2.33
Hold$16.6726.12% Upside
Select Medical Holdings Corporation stock logo
SEM
Select Medical
2.80
Moderate Buy$26.0075.38% Upside

Current Analyst Ratings Breakdown

Latest SEM, EHC, MD, and ARWR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/5/2025
Encompass Health Corporation stock logo
EHC
Encompass Health
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeOverweight ➝ Strong-Buy$135.00
5/27/2025
Encompass Health Corporation stock logo
EHC
Encompass Health
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$122.00 ➝ $135.00
5/20/2025
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$80.00 ➝ $80.00
5/13/2025
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$21.00 ➝ $17.00
5/13/2025
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$60.00 ➝ $60.00
5/12/2025
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$18.50 ➝ $16.00
5/8/2025
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$19.00 ➝ $20.00
5/7/2025
Select Medical Holdings Corporation stock logo
SEM
Select Medical
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$23.00 ➝ $19.00
4/28/2025
Encompass Health Corporation stock logo
EHC
Encompass Health
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$117.00 ➝ $130.00
4/28/2025
Encompass Health Corporation stock logo
EHC
Encompass Health
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$110.00 ➝ $125.00
4/28/2025
Encompass Health Corporation stock logo
EHC
Encompass Health
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$116.00 ➝ $135.00
(Data available from 6/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
$3.55M595.97N/AN/A$1.54 per share9.95
Encompass Health Corporation stock logo
EHC
Encompass Health
$5.37B2.23$7.55 per share15.77$27.72 per share4.30
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
$2.01B0.56$1.76 per share7.50$8.91 per share1.48
Select Medical Holdings Corporation stock logo
SEM
Select Medical
$5.19B0.37$2.50 per share5.93$15.35 per share0.97
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
-$599.49M-$1.40N/AN/A18.02N/A-45.33%-12.49%8/6/2025 (Estimated)
Encompass Health Corporation stock logo
EHC
Encompass Health
$455.70M$4.8424.6022.552.428.97%17.63%7.33%8/4/2025 (Estimated)
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
-$99.07M-$1.01N/A9.860.89-4.17%17.43%6.35%8/5/2025 (Estimated)
Select Medical Holdings Corporation stock logo
SEM
Select Medical
$214.04M$1.3411.0610.510.792.81%11.04%3.25%7/30/2025 (Estimated)

Latest SEM, EHC, MD, and ARWR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/12/2025Q2 2025
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
-$0.06$2.75+$2.81$2.75$116.27 million$542.71 million
5/6/2025Q1 2025
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
$0.25$0.33+$0.08$0.24$451.44 million$458.36 million
5/1/2025Q1 2025
Select Medical Holdings Corporation stock logo
SEM
Select Medical
$0.45$0.44-$0.01$0.44$1.40 billion$1.35 billion
4/24/2025Q1 2025
Encompass Health Corporation stock logo
EHC
Encompass Health
$1.19$1.37+$0.18$1.48$1.43 billion$1.46 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
N/AN/AN/AN/AN/A
Encompass Health Corporation stock logo
EHC
Encompass Health
$0.680.57%N/A14.05%2 Years
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
N/AN/AN/AN/AN/A
Select Medical Holdings Corporation stock logo
SEM
Select Medical
$0.251.69%N/A18.66%N/A

Latest SEM, EHC, MD, and ARWR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/1/2025
Encompass Health Corporation stock logo
EHC
Encompass Health
quarterly$0.170.59%7/1/20257/1/20257/15/2025
5/1/2025
Select Medical Holdings Corporation stock logo
SEM
Select Medical
quarterly$0.06251.37%5/15/20255/15/20255/29/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
0.31
5.15
5.15
Encompass Health Corporation stock logo
EHC
Encompass Health
0.81
1.06
1.06
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
0.75
1.81
1.81
Select Medical Holdings Corporation stock logo
SEM
Select Medical
0.87
1.16
1.16

Institutional Ownership

CompanyInstitutional Ownership
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
62.61%
Encompass Health Corporation stock logo
EHC
Encompass Health
97.25%
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
97.71%
Select Medical Holdings Corporation stock logo
SEM
Select Medical
89.48%

Insider Ownership

CompanyInsider Ownership
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
4.30%
Encompass Health Corporation stock logo
EHC
Encompass Health
2.10%
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
0.90%
Select Medical Holdings Corporation stock logo
SEM
Select Medical
11.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
400138.10 million132.16 millionOptionable
Encompass Health Corporation stock logo
EHC
Encompass Health
40,000100.80 million98.68 millionOptionable
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
4,30585.91 million85.13 millionOptionable
Select Medical Holdings Corporation stock logo
SEM
Select Medical
44,100128.54 million113.63 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Arrowhead Pharmaceuticals stock logo

Arrowhead Pharmaceuticals NASDAQ:ARWR

$15.32 -0.30 (-1.92%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$15.35 +0.03 (+0.20%)
As of 06/20/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes Plozasiran, which is in Phase 2b and one Phase 3 clinical trial to treat hypertriglyceridemia, mixed dyslipidemia, and chylomicronemia syndrome; Zodasiran that is in Phase 2b clinical trial for the treatment of dyslipidemia and hypertriglyceridemia; ARO-PNPLA3, which is in Phase 1 clinical trial to treat patients with non-alcoholic steatohepatitis; ARO-RAGE that is in Phase 1/2a clinical trial to treat inflammatory pulmonary conditions; and ARO-MUC5AC, which is in Phase 1/2a clinical trial to treat muco-obstructive pulmonary diseases. It also develops ARO-MMP7 that is in Phase 1/2a clinical trial for treatment of idiopathic pulmonary fibrosis; ARO-DUX4 for the treatment of facioscapulohumeral muscular dystrophy; ARO-SOD1 for the potential treatment of amyotrophic lateral sclerosis; and ARO-C3, which is in Phase 1/2a clinical trial for the treatment of patients with various complement mediated or complement associated renal diseases. In addition, the company is involved in the development of JNJ-3989, which is in Phase 2 clinical trial to treat chronic hepatitis B virus infection; Olpasiran that is in Phase 3 clinical trial to reduce the production of apolipoprotein A; GSK-4532990 that is in phase 2 clinical trial to treat liver diseases; HZN-457, which is in phase 1 clinical trial to treat uncontrolled gout; and Fazirsiran that is in Phase 3 clinical trial for the treatment for liver disease associated with alpha-1 antitrypsin deficiency. Arrowhead Pharmaceuticals, Inc. has license and research collaboration agreements with Janssen Pharmaceuticals, Inc.; Takeda Pharmaceutical Company Limited; Horizon Therapeutics Ireland DAC; Amgen Inc.; and Glaxosmithkline Intellectual Property (No. 3) Limited. The company was founded in 2003 and is headquartered in Pasadena, California.

Encompass Health stock logo

Encompass Health NYSE:EHC

$119.07 -0.68 (-0.57%)
Closing price 06/20/2025 03:59 PM Eastern
Extended Trading
$118.64 -0.44 (-0.37%)
As of 06/20/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.

Pediatrix Medical Group stock logo

Pediatrix Medical Group NYSE:MD

$13.22 -0.14 (-1.01%)
Closing price 06/20/2025 03:59 PM Eastern
Extended Trading
$13.22 +0.01 (+0.08%)
As of 06/20/2025 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals, including pediatric nurse practitioners, echocardiographers, other diagnostic technicians, and exercise physiologists; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians, pediatric gastroenterologists; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Select Medical stock logo

Select Medical NYSE:SEM

$14.82 -0.10 (-0.64%)
Closing price 06/20/2025 03:59 PM Eastern
Extended Trading
$14.84 +0.01 (+0.07%)
As of 06/20/2025 06:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra. The Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. The Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer. The Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services. The Concentra segment operates and provides occupational health centers, telemedicine platforms, onsite clinics, and contract services at employer worksites that deliver occupational health services, consumer health, physical therapy, and preventive care. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.